Wilzhofen, Germany

Knut Bartl


Average Co-Inventor Count = 3.0

ph-index = 10

Forward Citations = 244(Granted Patents)


Location History:

  • Tutzing, DE (1980 - 1981)
  • Wilzhofen, DE (1983 - 1991)

Company Filing History:


Years Active: 1980-1991

Loading Chart...
14 patents (USPTO):Explore Patents

Title: **Innovative Contributions of Knut Bartl in Blood Coagulation Testing**

Introduction

Knut Bartl, an esteemed inventor based in Wilzhofen, Germany, has made significant strides in the field of blood coagulation testing. With an impressive portfolio of 14 patents, his work has had a profound impact on medical diagnostics and treatment.

Latest Patents

Knut Bartl's latest inventions demonstrate his commitment to advancing medical technology. One of his notable patents is a dry reagent for blood coagulation tests, which enables an at least partial course of the coagulation cascade. This invention comprises a carrier material containing a chromophoric substrate of a protease from the blood coagulation system, along with key factors and co-factors and a buffer. Another significant contribution is the process for photometric determination of protein C and/or protein S activity, particularly in plasma. This procedure involves incubating a sample with a protein C activator derived from snake venom, leading to the formation of activated protein C and/or protein S. The process then determines the decrease in thrombin formation from prothrombin, enhanced by coagulation factors and their activators, using a chromogenic thrombin substrate.

Career Highlights

Knut Bartl is notably associated with Boehringer Mannheim GmbH, where his innovative work has been instrumental in developing reliable diagnostic tools for blood coagulation analysis. His ability to blend scientific research with practical application is reflected in his successful patent filings and the implementation of his inventions in medical settings.

Collaborations

Throughout his career, Knut Bartl has worked alongside distinguished colleagues such as Helmut Lill and Joachim Ziegenhorn. These collaborations have fostered an environment of creativity and innovation, leading to significant advancements in the domain of blood coagulation testing.

Conclusion

Knut Bartl’s contributions to the field of blood coagulation diagnostics illustrate the critical role of innovation in healthcare. With his ongoing dedication to research and development, he continues to inspire future inventors in the pursuit of medical advancements that can improve patient outcomes and elevate the standards of diagnostic testing.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…